Bone targeted therapy and skeletal related events in the era of enzalutamide and abiraterone acetate for castration resistant prostate cancer with bone metastases
Published in
Prostate Cancer and Prostatic Diseases, September 2020
Pharmacology, Toxicology and Pharmaceutical Science
2
8%
Biochemistry, Genetics and Molecular Biology
1
4%
Nursing and Health Professions
1
4%
Psychology
1
4%
Other
0
0%
Unknown
13
54%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 January 2021.
All research outputs
#6,300,918
of 24,003,070 outputs
Outputs from Prostate Cancer and Prostatic Diseases
#588
of 1,154 outputs
Outputs of similar age
#130,726
of 402,923 outputs
Outputs of similar age from Prostate Cancer and Prostatic Diseases
#24
of 36 outputs
Altmetric has tracked 24,003,070 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 1,154 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.7. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 402,923 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 36 others from the same source and published within six weeks on either side of this one. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
